Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03801226Phase 1Completed
Phase 1, randomised trial of dextrose in heart failure (HF) and Volume overload (2 arms), sponsored by Yale University. Primary endpoint: Protocol discontinuation due to patient discomfort or adverse event at 2 hours. Started Dec 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03801226.